Neurofibroma - 63 Studies Found
| Active, not recruiting |
: A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1 : Neurofibromatosis Type 1 : 2009-02-23 :
|
| Active, not recruiting |
: Resiliency Training for Adolescent Neurofibromatosis Patients Via Videoconferencing With Skype : Neurofibromatoses : 2015-02-25 :
|
| Completed |
: Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1) : Neurofibromatosis 1 : 2006-07-13 :
|
| Completed |
: Neuropsychological Impairment and Quality of Life in Neurofibromatosis Type 1 : Neurofibromatosis Type 1 : 2013-04-24 : Other: Neuropsychological examination and quality of life measures |
| Completed |
: Multi-Center Project: Spinal Abnormalities in Neurofibromatosis Type1 (NF1) Patients : Neurofibromatosis Type 1 : 2008-04-24 |
| Suspended |
: PTC299 for Treatment of Neurofibromatosis Type 2 : Neurofibromatosis 2 : 2009-05-28 : Drug: PTC299 PTC299 will be administered orally at 100 mg/dose twice per day for up to 1 year or until t |
| Completed |
: Everolimus for Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis1 CRAD001CUS232T : Neurofibromatosis 1 : 2014-12-12 : Drug: Everolimus Everyone in the study will receive Everolimus at a starting dose of 10 mg daily and wil |
| Completed |
: NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate : Neurofibromatosis Type 1 : 2005-09-09 : Drug: methylphenidate |
| Completed |
: Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2 : Neurofibromatosis Type II : 2011-08-17 : Drug: Everolimus (RAD001) , Afinitor® Everolimus will be provided by Novartis. Everolimus is formul |
| Completed |
: Spinal Abnormalities in Neurofibromatosis Type 1 (NF1) : Neurofibromatosis Type 1 : 2009-02-12 |